MONOCLONAL ANTIBODIES AGAINST APOLIPOPROTEIN M
The invention describes monoclonal antibodies that have the capacity to immunoreact with human apolipoprotein M (apoM). Such antibodies can be used in methods for determining apoM and also in methods for purification of apoM or enrichment of apoM-containing lipoprotein particles.